Pterygium
Also known as: Conjunctival pterygium, Conjunctival fibrovascular growth, Surfer's eye
Pterygium is a benign fibrovascular proliferation originating from the bulbar conjunctiva that encroaches upon the corneal surface. It may induce ocular irritation, corneal astigmatism, and secondary visual impairment. Clinical eye-care assessment is imperative for diagnosis, monitoring of progression, and surgical determination. TCM intervention serves as an adjunctive modality directed at symptom management or perioperative support, rather than lesion resolution. Evidence includes a randomised trial involving 110 surgical patients demonstrating improved analgesia, anxiety reduction, and recovery outcomes 24 hours postoperatively via transcutaneous electrical acupoint stimulation at LI4 and PC6. These data do not support the efficacy of filiform acupuncture for lesion regression or recurrence prophylaxis. Clinical evidence for herbal medicine is absent; traditional patterns are presented as diagnostic frameworks rather than validated clinical subtypes.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Utilise UV-protective wraparound sunglasses and broad-brimmed headwear during all outdoor exposure.
- •Employ appropriate protective eyewear when encountering particulate-heavy or aeolian environments.
- •Refrain from mechanical irritation (rubbing) of the eye and avoid the application of non-sterile or extemporaneous herbal preparations.
- •Maintain adherence to all scheduled ophthalmological reviews and strictly observe postoperative protocols regarding topical medications and physical exertion.
Cautions & Contraindications
- •Do not needle the pterygium, ocular surface, surgical graft or inflamed periocular tissue. Avoid periocular procedures during postoperative healing unless specifically cleared by the ophthalmologist. These are procedural safety precautions, not findings tested by the supplied surgical study.[]
- •The LI4/PC6 trial studied supervised perioperative TEAS, not self-treatment, ocular stimulation or needle acupuncture. Check skin integrity, sensation and implanted electronic devices, following device guidance and perioperative team clearance; these exclusions are not established by the supplied abstract.[]
- •Do not substitute herbs or acupuncture for excision assessment when vision is threatened, or for prescribed postoperative care. The bibliometric paper maps surgical research and does not establish efficacy of adjunctive therapies.[]
When to reassess or seek care again
Record baseline irritation and dryness on 0–10 scales, functional impact and eye-care findings. Review adjunctive symptom care after 2–4 weeks and stop or reconsider if there is no meaningful improvement or adverse effects occur. Lesion extent, visual acuity and astigmatism require eye-care monitoring at the clinician's chosen interval. New visual deterioration or documented growth prompts ophthalmology review; acute red flags require same-day assessment. After surgery, follow the surgeon's schedule rather than this adjunctive interval.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Medicine · 2026
- Frontiers in neurology · 2025
- Scientific reports · 2026
- Orphanet journal of rare diseases · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
